Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the field of medicine, can solve the problems of poor patient effect
Inactive Publication Date: 2018-09-25
郭秋玲
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there are still a small number of patients who respond poorly to this treatment
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
experiment example 1
[0021] The characterization of experimental example 1 medicine of the present invention
[0025] Experimental example 2 The therapeutic effect of medicine of the present invention for asthma
[0026] Sixty healthy female Kunming mice were randomly divided into a normal group of 10 and a model group of 30 after weighing.
[0027] Preparation of Mouse Allergic Asthma Model
[0028] Mice in the model group were induced by mites (HDM) as a mouse allergic asthma model: after mixing 25 μg of crude HDM extract with 10 μL of 0.9% NaCl, each mouse was intranasally instilled with 10 μL each time, 5 times a week, for 7 consecutive days. week. The mice in the normal group were intranasally instilled with 10 μL of normal saline, and the procedure was the same as above.
[0029] Animal grouping and dosing
[0030] The model mice were divided into a model group, a positive control group and a drug group of the present invention, with 10 mice in each group.
[0031] After 5 weeks of sensitization, the mice of the drug group of the present invention were administered with 10 mg...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The present invention relates to an asthma treating pharmaceutical composition, which comprises a compound and any one or a variety of pharmaceutically acceptable carriers. The invention further discloses uses of the compound in preparation of asthma treating drugs, wherein the compound can be prepared in any one pharmaceutically acceptable preparation. According to the present invention, the asthma treating pharmaceutical composition can reduce the high-level expression of IL-17, IL-6, TNF-alpha and TGF-beta in pulmonary alveoli due to allergic asthma, can improve the pathological changes oflung tissue to a certain extent, and has a certain anti-inflammatory and anti-pulmonary fibrosis effect so as to achieve the purpose of asthma treating drugs.
Description
technical field [0001] The invention relates to the field of medicine, in particular, the invention relates to a pharmaceutical composition for treating asthma. Background technique [0002] Allergic asthma is the release of mediators mediated by IgE after exposure to allergens in atopic individuals. It is a chronic airway inflammatory response disease involving a variety of immune active cells and cytokines. Most patients respond well to treatment with inhaled corticosteroids and β-adrenoceptor agonists. However, there are still a small number of patients who respond poorly to this treatment. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating asthma. [0004] In order to realize the purpose of the present invention, the present invention provides a kind of pharmaceutical composition for treating asthma, and described pharmaceutical composition comprises the component with following formula struc...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more